# Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte

> **NCT07427576** · — · COMPLETED · sponsor: **Inmunotek S.L.** · enrollment: 140 (actual)

## Conditions studied

- Mite Allergy
- Dermatophagoides Farinae Allergy
- Dermatophagoides Pteronyssinus Allergy
- Rhinitis, Allergic
- Asthma
- Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** Clustoid® Max Forte

## Key facts

- **NCT ID:** NCT07427576
- **Lead sponsor:** Inmunotek S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-31
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07427576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07427576, "Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07427576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*